Skip to search formSkip to main contentSkip to account menu

CVT 510

Known as: CVT-510 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

tecadenoson

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Electrophysiologic Disorders Termination of Paroxysmal Supraventricular Tachycardia by Tecadenoson ( CVT-510 ) , a Novel A 1-Adenosine Receptor Agonist
Termination of Paroxysmal Supraventricular Tachycardia by Tecadenoson (CVT-510), a Novel A1-Adenosine Receptor Agonist Eric N… 
2013
2013
INO-8875, a Highly Selective A1 Adenosine Receptor Agonist: Evaluation of Chronotropic, Dromotropic, and Hemodynamic Effects in Rats
Selective pharmacological activation of the adenosine 1 receptor (A1R) is a promising new approach to achieve a potent block of… 
2010
2010
INO-8875, a Highly-Selective A1 Adenosine Receptor Agonist: Evaluation of Chronotropic, Dromotropic and Hemodynamic Effects in Rats.
Publication of this article is suspended until the authors can provide full identification and verification of the chemical… 
Review
2006
Review
2006
CVT-510: a selective A1 adenosine receptor agonist.
Adenosine is an endogenous nucleoside that has potent antiarrhythmic effects on paroxysmal supraventricular tachycardia (PSVT… 
2003
2003
Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist.
2003
2003
N-[3-(R)-Tetrahydrofuranyl]-6-aminopurine Riboside, an A1 Adenosine Receptor Agonist, Antagonizes Catecholamine-Induced Lipolysis without Cardiovascular Effects in Awake Rats
Elevated serum nonesterified free fatty acid (NEFA) concentrations are detrimental to both the mechanical and electrical function… 
Review
2002
Review
2002
CVT-510 (CV Therapeutics).
CVT-510, the lead compound from a series of selective adenosine A1 receptor agonists, is being developed by CV Therapeutics for… 
2001
2001
Electrophysiologic Effects of a Novel Selective Adenosine A1 Agonist (CVT-510) on Atrioventricular Nodal Conduction in Humans
Background: CVT-510, N-(3(R)-tetrahydrofuranyl)-6-aminopurine riboside, is a selective A,-adenosine receptor agonist with… 
2001
2001
Negative chronotropic effect of CVT‐510 in anesthetized and awake rats
CVT‐510 (N‐(3(R)‐tetrahydrofuranyl)‐6‐aminopurine riboside), a selective A1 adenosine receptor (AdoR) agonist, is being developed… 
1999
1999
A comparison of an A1 adenosine receptor agonist (CVT‐510) with diltiazem for slowing of AV nodal conduction in guinea‐pig
The purpose of this study was to compare the pharmacological properties (i.e. the AV nodal depressant, vasodilator, and inotropic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)